Prevalence of K-Ras mutations in hepatocellular carcinoma: A Turkish Oncology Group pilot study

Molecular and Clinical Oncology
Nazim Serdar TurhalMehmet Artaç

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common male-predominant type of cancer worldwide. There is no effective treatment regimen available for advanced-stage disease and chemotherapy is generally ineffective in these patients. The number of studies on the prevalence of K-Ras mutations in HCC patients is currently limited. A total of 58 patients from 6 comprehensive cancer centers in 4 metropolitan cities of Turkey were enrolled in this study. Each center committed to enroll approximately 10 random patients whose formalin-fixed paraffin-embedded tumor tissues were available for K-Ras, exon 2 genotyping. Two methods were applied based on the availability of adequate amounts of tumor DNA. In the first method, the samples were processed using TheraScreen. The genomic DNA was further used to detect the 7 most frequent somatic mutations (35G>A; 35G>C; 35G>T; 34G>A; 34G>C; 34G>T and 38G>A) in codons 12 and 13 in exon 2 of the K-Ras oncogene by quantitative polymerase chain reaction (PCR). In the second method, the genomic DNA was amplified by PCR using primers specific for K-Ras exon 2 with the GML SeqFinder Sequencing System's KRAS kit. The identified DNA sequence alterations were confirmed by sequencing both DNA strands in...Continue Reading

References

Jul 19, 2001·Journal of the National Cancer Institute·A A Adjei
Sep 21, 2001·International Archives of Occupational and Environmental Health·M WeihrauchA Tannapfel
Mar 5, 2003·Teratogenesis, Carcinogenesis, and Mutagenesis·Feng BaiNobuyuki Hara
Mar 14, 2008·The New England Journal of Medicine·Fortunato Ciardiello, Giampaolo Tortora
Aug 30, 2008·Japanese Journal of Clinical Oncology·Ahmet AlacaciogluUgur Yilmaz
Dec 17, 2010·World Journal of Gastrointestinal Oncology·Luigi RossiSilverio Tomao
Jan 1, 2009·Therapeutic Advances in Gastroenterology·Kathleen E Corey, Daniel S Pratt
Apr 28, 2012·Gastroenterology·Hashem B El-Serag
Sep 4, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Erkan DoganAydemir Olmez
Dec 26, 2012·Surgery Today·Akinobu TaketomiYoshihiko Maehara
May 2, 2013·Journal of Clinical Gastroenterology·Sahil Mittal, Hashem B El-Serag
Aug 28, 2013·Clinical Colorectal Cancer·Shao-Chun ChangChristopher Harbison
Sep 7, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G RubovszkyE Hitre
Sep 13, 2013·The New England Journal of Medicine·Jean-Yves DouillardScott D Patterson
Nov 26, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Audrey ValléeMarc G Denis
Jan 29, 2014·Current Cancer Drug Targets·Min ShiJun Zhang
Mar 4, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G FolprechtC-H Köhne
Mar 13, 2014·Applied Immunohistochemistry & Molecular Morphology : AIMM·Julia A AdamsLiang Cheng
Apr 26, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Alper CanAhmet Alacacioglu

❮ Previous
Next ❯

Citations

Jun 29, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ho Yeong LimJosep M Llovet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.